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In the first paper of this series (1) it was shown that when mixtures 
of the virus of equine encephalomyelitis, Eastern or Western strain, 
and  its  antiserum, are  inoculated intraperitoneally in  12  to  15  day 
old mice, protection is obtained against much larger amounts of virus 
than  when  the  mixtures  are  given  intracerebrally.  That  is,  with 
the  same material,  1  to  1,000  cerebral  infective doses of virus are 
neutralized  by  the  intracerebrai  method as  compared with  10,000 
to  1,000,000  peritoneal doses by the intraperitoneal. 
The purpose of the present study was to determine the mechanism 
underlying the more potent action  exerted by  the antiviral  serum 
by one route than by another.  At the outset it should be mentioned 
that it has not proved possible thus far to elucidate this completely; 
the  experimental results have  served to  eliminate, however, divers 
theories hitherto offered to account for the phenomenon, to delimit 
more closely the place where the immune mechanism may be con- 
summated and, what is more important, to correlate the mechanism 
of immunity with the pathways taken by the virus from the point of 
inoculation at various sites to the central nervous system. 
In the first  communication  (I),  mention was made of the work with other 
viruses  in  which it  was shown that the protective  power of  serum-virus mixtures 
depends to  a  large  extent  on  the  route  of  inoculation.  A summary follows  of  some 
of the interpretations  of  this  reaction  presented by earlier  investigators,  together 
with the bearing of our previous work on the question as it applies  to  equine 
encephalomyelitis  in  the  mouse. 
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Thus  Cralgie and TuUoch  (2)  considered the possibility  that  differences  in 
protection according to route might be explained,  in the ease of vaccine virus and 
its antiserum, on the ground of greater susceptibility of one organ (e.g., testis) 
to  the  virus  than  another  (skin).  On  the other  hand,  Sahin  (3)  studied  the 
problem of greater sensitivity of certain tissues to the action of vaccinla, herpes, 
B virus, and pseudorabies viruses, to note whether smaller amounts of these infec- 
tive agents could be detected that way and hence more serum required for pro- 
tection.  With strictly quantitative methods in which the minimal infective doses 
were the same by two different routes, and by varying the amounts of serum 
and virus,  Sabin  found  that  the  difference  in  protective capacity of mixtures 
could not be ascribed to the fact that one route may be more sensitive than an- 
other in detecting small amounts of virus.  The results with equine encephalomye- 
litis virus, as already reported (1), confirmed the latter findings.  With this virus, 
the lesser degree of protection by a given route (intracerebral) did not depend on 
the greater sensitivity of that tissue for detection of the infective agent.  It was 
shown that one minimal infective dose of virus by the intraperitoneal route in 
12 to 15 day old mice was approximately the same as by the intracerebral, yet the 
same amount of serum protected against many more doses by the former than by 
the latter route of inoculation. 
Andrewes  (4)  ohtained greater protection with antivacclnial serum by intra- 
dermal inoculation than by other routes and he suggested that this might be due 
to less ready diffusion of antibody in that site.  Again the experiments of Sabin 
(3) indicated that this might not be the exphnation: when the virus was used as a 
suspension of testicular tissue, marked diffusion took place from the action of the 
Duran-Reynals spreading factor of testicular tissue but the protective effect of 
the serum was, nevertheless, apparent. 
That the difference in protective power depends on unknown factors peculiar 
to the tissue itself was indicated by the phenomenon described by Shope (5) in 
which mixtures of immune serum and pseudorabies virus which are innocuous 
subcutaneously in the guinea pig, produced fatal infection when given by the same 
route  to  the  rabbit.  Thls problem was  also  studied  quantitatively  by Sabin 
(3) and it was disclosed that the varying protective capacity of anti-pseudorabies 
serum in rabbits and guinea pigs was not due to the greater sensitivity of the sub- 
cutaneous tissue of rabbits in revealing smaller amounts of virus but rather to 
other conditions in this tissue of both species that may be only indirectly related 
to their susceptibility.  Thus the results depended more on species involved than 
on  route  of inoculation.  In  this  connection  the  investigator also  studied  the 
possibility of pseudorabies virus being fixed or entering the susceptible cells more 
rapidly or in greater quantity than the immune serum when the two are injected 
subcutaneously in rabbits.  One must restrict oneself  to measured quantities of 
materials in such trials: when such quantitative relationships were brought into 
consideration  (3),  and  when  subeffective amounts  of  serum  were  injected  at 
intervals before virus in the same cutaneous sites, the writer concluded that no 
protection was gained.  It is therefore probable that the poor protection by this 
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Findiay  (6)  investigated  anew  the finding of Francis  and  Magill (7)  that 
antiserum of the virus of Rift Valley fever protected against more virus when the 
serum-virus mixtures were given mice intraperitoneally  rather than intranasally. 
Findiay  pointed  out that in this instance the difference in protective  capacity 
depended on the amount of inoculum, for when the dose was equal no variation 
occurred.  In the preceding paper  (1), it was shown, however, that with equine 
encephalomyelitis virus,  variation  in  the protective  capacity  of antiserum  by 
intraperitoneal and intmcerebral methods of injections persisted when the amount 
of inocnlum given was the same for both routes.  In addition, the variation was 
still evident not only when the ages of the mice employed in the two methods were 
equal but also when the serum-virns m~tures were administered either freshly 
prepared or incubated for 2½ hours at 37°C. 
It was brought out previously (1) and this is in agreement with the work of 
Sabin on other viruses (3), that  the variation  in protective  power by the two 
routes, intracerebral  and intraperitoneal,  was in itself evidence that  the action 
of the antiserum against equine encephalomyelitis virus was not an in vitro effect 
but was contingent upon the tissues into which it was injected. 
The  foregoing  summary  brings  to  light  the  fact  that  while  the 
precise mechanism underlying the variation in the protective potency 
of antiserum-virus  mixtures,  when  administered  by different routes, 
is still unknown,  certain  theories  advanced to explain this variation 
are  not  consistent  with  experimental  data  subsequently  obtained. 
The virus now being studied was found to resemble in a  general way 
several other viruses in  that  the  effect of its  antiserum  is not  con- 
summated  in  vitro  and  that  the  variation  in  protective  capacity is 
not  primarily  the  result  of  the  dose  of  inoculum  or  incubation  of 
serum-virus mixtures but is influenced by the tissues into which such 
mixtures are injected (1).  In this latter connection, no definite proof 
could be offered that  the variation is dependent on the greater  sen- 
sitivity of the tissues of one route to detect small amounts of virus 
over that of another. 
For the purposes of the present investigation,  namely, the elucida- 
tion of the mechanism involved in the variation of protective capacity 
by two routes of inoculation,  the approach to the problem consisted 
of  inoculation  of  serum  intraperitoneally  followed by the injection 
of virus  by various  routes.  The  results were then  correlated  with 
the pathways known to be taken by the virus according to the route 
of inoculation.  In so doing, use was made of the knowledge at hand 
of the pathogenesis of the Eastern strain of the virus, that is, of the 
pathways pursued by it after its inoculation into mice at various sites. 764  VIRUS  OF  EQUINE  ENCEPHALOMYELITIS.  II 
Sabin (8) and Sabin and Olitsky (9, 10) have employed a method of partial 
serial tissue section of mouse (and guinea pig)  central nervous system combined 
with tests for detection of virus by inoculation of animals,  and have been able 
thereby to indicate the localization of lesions  and  virus,  thus delineating the 
probable pathways of the infective agent from the periphery to the central ner- 
vous system.  After intranasal instillation of Eastern equine encephalomyelitis 
virus into young or old mice,  the central nervous system is invaded along the 
olfactory pathway.  After  intraperitoneal  or  intramuscular  injection  of  this 
virus into 15 day old mice,  it becomes  demonstrable in the blood,  and in the 
greater number of the animals, it migrates from the blood onto the nasal mucosa, 
whence it invades  the central nervous  system by the olfactory pathway.  In 
some of these mice, however, invasion of the central nervous system occurs along 
the local peripheral nerves or along the auditory nerve pathway and possibly 
along the seventh nerve fibers.  It has also been shown that while the virus enters 
and persists  or mnltiplies in the drculating blood, no evidence was found of a 
direct passage of virus across the blood vessels of the brain (8-10). 
Methods 
These were essentially the same as those previously employed (1).  The serum 
studied was the hyper~romune rabbit serum--the same sample was used throughout 
this work; the virus, the Eastern strain of equine encephalomyelitis,  and the mice, 
the Rockefeller Institute albino strain of 12 to 15 days of age (unless otherwise 
mentioned).  The mode of procedure, preparation of materials, and dosages were 
described in the first paper (1) and need not be repeated here. 
Experiments on Passive Immunity 
It  was  planned  to  inject  mice  with  hyperimmune  serum  intra- 
perltoneally in varying amounts and to follow this at certain intervals 
by administration  of virus in different sites,--brain,  nose, peritoneal 
cavity,  and  leg  muscles.  In  other  tests  antiserum-virus  mixtures 
were inoculated into  the tissues mentioned; the results of the latter 
trials would serve as a check on those in which the serum was injected 
in  advance of the  virus.  It was  believed that  by these means  the 
virus could be placed either in the brain  itself or in peripheral  sites 
from which  regions  it would  invade the  central  nervous system via 
the pathways  already designated;  the virus  and  tissues  would then 
be under the influence of antiviral serum given either along with or 
before the infective agent.  From the outcome of such  experiments 
indications might be derived as to the relationship of pathways trav- 
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Passive immunization experiments with this virus have already been reported. 
Howitt (11) introduced serum into  the muscles of guinea pigs and found them 
resistant  to intracerebral  inoculation  of virus;  also Rottgardt and Riglos (12) 
gave serum intraperitoneally  to guinea pigs and found them refractory either to 
an intracerebral or to a combined intranasal and subcutaneous test dose.  These 
experiments were not performed on a quantitative  basis, thus making it impossible 
or difficult to apply these data to the elucidation of the problem under considera- 
tion here. 
In the following experiment an effort was made to determine quan- 
titatively  the  protective  capacity  of  a  certain  amount  of  serum, 
given  in  the  peritoneal  cavity,  against  virus  introduced  directly 
into the brain. 
Serum Given Intraperitoneally,  Virus Intracerebrally.l--In  the first 
test  15 day old mice were injected intraperitoneally  with the rabbit 
hyperimmune serum in the amounts indicated in Table I, and Eastern 
equine  encephalomyelitis virus intracerebraUy  in  varying  doses and 
at the intervals as noted in the table in Experiments  1 to 3. 
The  results  recorded indicate  that  even with as much  as 2  cc.  of 
hyperimmune  serum  given  intraperitoneally--the  largest  amount 
that can be given safely in this way to 15 day old mice--either very 
little protection or only a  questionable one could be secured against 
virus introduced intracerebrally 24 hours later.  The result is similar 
to that achieved when serum-virus mixtures were used (1).  There is 
striking  contrast  between  this  effect  and  that  resulting  from  the 
inoculation of 1/133 of this amount  (0.015 cc.) of serum mixed with 
virus  and  administered  intraperitoneaily  whereby  protection  was 
afforded against  10,000 to 1,000,000 infective doses (1).  From these 
tests it is apparent  that  a  low degree of protection,  or none  at  all, 
results when the virus is given into the brain which is the main seat 
of viral attack.  The next step was to disclose  any  difference in re- 
action when  the  virus was inoculated  peripheraily  rather  than  cen- 
trally; the nasal route was the first to be tried. 
Serum Given Intraperitoneally,  Virus Intranasally.--Sabin  (13) has 
already shown that  the intraperitoneal  injection of 1 cc. of immune 
serum, or the' equivalent of 50 cc. per kilo, given 4 hours before infec- 
tion,  protected mice  against  a  lethal  amount  of  this  virus  instilled 
x  All such operations were performed with the aid of ether anesthesia. 766  VIRUS  O~  EQUINE  ENCEPHALOMYELITIS.  [I 
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intranasally.  It was now desirable to know whether the small amount 
of  serum  used  in  our  experiments for  demonstration of  protective 
antibody by  the  intraperitoneal  route  (0.015  cc.)  might  have  the 
same or a  different effect.  As a  control, and furthermore  to check 
the results obtained in the previous passive protection test  in which 
the intracerebral route for inoculation of virus and large amounts of 
serum were used, this latter test was repeated with the small amount 
of antiserum. 
For this purpose, 15 day old mice received rabbit serum intraperitoneally-- 
one group, normal serum and the other, hyperlmmune--in a dose of 0.015 cc. 
each.  The sera were diluted 1:1 in saline solution so as  to make for  greater 
accuracy in measurement of the amounts needed as inocula.  4 hours later they 
were given either intranasal or intracerebral test doses  of various dilutions of virus, 
the dose by both routes being 0.03 cc.  The results are shown in Experiment 4, 
Table I. 
The data reveal that in the mice receiving virus peripherally, no 
protective influence of the serum could be discerned.  As was  to be 
expected, the control group of animals having been given  virus cen- 
trally, again showed a low degree of protection, that is,  against only 
one infective unit.  A  similar outcome  was found on repetition, as 
recorded in Table II.  It would appear, therefore, that by intranasal 
and  intracerebral  methods  the  immune  serum  exhibited  in  both 
instances the same low or ineffective neutralization. 
The results are now reported of passive immunity tests  in which 
virus was given by other peripheral routes, namely,  the intramuscular 
and intraperitoneal. 
Serum  Given  Intraperitoneally,  Virus  Intraperitoneally  or  Intra. 
muscularly.--The  plan of this experiment was to introduce immune 
serum  intraperitoneally and  to  follow it later by the  simultaneous 
injection of virus, intramuscularly in one group of 15  day old mice 
and intraperitoneally in another. 
As will  be noted in Experiment 5, Table I, hyperimmune  rabbit serum was given 
intraperitoneally in doses of 0.015 cc. (as in Experiment 4) followed  4 hours later 
by an intramuscular inoculation (muscles of a posterior extremity) of 0.03 cc. 
of each dilution of virus.  (A preliminary titration of virus activity by this route 
exhibited the limiting titer of infectivity in the 10  -s dilution.)  Intraperitoneal 
inoculations were made at the same time in another  group of serum-treated  15 
day old mice, employing  the same amount of inoculum,  0.03 cc. 768  VIRUS OF EQUINE ENCEPHALOMYELITIS.  II 
The  results reveal that  the immunity to intramuscularly  or intra- 
peritoneally injected virus after serum has been given intraperitoneally 
is of a remarkably high degree.  The serum induced protection against 
at least 10,000 minimal intramuscular infective doses introduced into 
the muscles, and at least 100,000 peritoneal units inoculated into the 
peritoneal  cavity.  (A  still  higher  degree of resistance  to intramus- 
cularly introduced virus is shown in Table II.)  It is therefore clear 
that on the basis of effective protection as revealed by the methods 
employed,  the  administrations  of  virus  by the  intramuscular  and 
TABLE II 
Passive Immunity  to  Virus Introduced Intraccrebrally, Intranasally,  and 
Intramuscularly 
Amount  of 
serum 
Im-  Nor- 
mune  real 
$C.  $$, 
£).015 
0.015 
1.015 
0.015 
).015 
0.015 
4~ 
5* 
5* 
4½* 
4½* 
4 
4 
Number of mice developing encephalitis 
of three injected 
10-1  10-~ 
;I- 
1  0 
loS  10  "~  i0-~ 
.J 3 
3  310 
3  2  2 
0  0 
10-6  10-7  10S 
l 
3  1 
--'  --  3 
0 
1 
3  3  2 
lO-9 
0  0 
I  0 
Minimal infective doses in 
terms of route, against which there 
was protection 
Intracere- 
bral doses 
1 
Control 
Intranasal 
doses 
1 
Control 
Intra- 
muscular 
doses 
10,000,00~ 
Control 
Abbreviations as in Table I. 
Mice were a mixture of the ages of 12, 13, and 14 days. 
* Intervals  due to the time used in inoculation. 
intraperitoneal  routes  (peripheral)  align  themselves  in  one  class  of 
high  protective  capacity,  the  nasal (peripheral)  and  the  cerebral 
(central)  in  another  of  low  protective  power.  However,  all  the 
experiments on which this classification is based were not performed 
at the same time;  this factor was therefore taken into  consideration 
in the next test in which was studied the simultaneous use of intra- 
cerebral,  intranasal,  and  intramuscular  methods. 
Comparison of Results with Serum Given Intraperitoneally and Virus 
Intracerebrally,  Intranasally,  and  Intramuscularly.--The  procedures 
followed  in  this  experiment  are  outlined  in  Table  II.  From  the PETER  K.  OLITSKY  AND  CARL  G.  HARFORD  769 
results it is apparent that again hyperimmune serum injected intra- 
peritoneally yielded protection against only one cerebral or nasal in- 
fective  unit  when  virus  was  administered  intracerebrally  or  intra- 
nasally, and against as many as 10,000,000 intramuscular units when 
the  virus  was  inoculated  intramuscularly.  The  remarkable  fact 
brought to light is that such a relatively minute quantity of antiserum 
(0.015 cc.) can be capable of exerting so high a  degree of protective 
effect, even though the serum is introduced into the abdominal cavity 
and  the  virus  into  the  muscle.  Another interesting observation  is 
revealed in these experiments as well as in those recorded in Table 
III.  Less  virus  is  required  to  induce  encephalitis  after  its  intra- 
muscular rather than intranasai introduction.  This may be taken as 
evidence that the virus may multiply before arriving at the central 
nervous  system.  The  larger  amounts  of  virus  needed  to  produce 
encephalitis after its intranasal instillation may be explained by the 
fact that  a  great  deal of it is washed away.  It  should be stressed 
also  that  the  intramuscular  minimal  infective  dose  of  virus  is the 
same as the intracerebral  and often the same as the intraperitoneai. 
Up  to  this point  experiments were made on  the basis  of passive 
immunity with the antiserum given prior to the virus.  The results, 
however, are in accord with those already reported  (1),  which were 
derived from tests with serum-virus mixtures injected intracerebrally 
and intraperitoneally.  In  the following a  comparison was made of 
the  effects  secured  from  the  inoculation  of  serum-virus  mixtures 
intranasally  as an example of a  route by which only low protective 
potency is demonstrable, and intramuscularly, where high protective 
capacity is discerned. 
Comparison of Infectivity  of Serum-Virus  Mixtures  by  Intranasal 
and  Intramuscular  Routes 
Serum-virus mixtures,  without incubation,  were inoculated  intramuscularly 
or intranasally into groups of mice 14 or 15 days old.  The amount of inoculum 
by both routes was 0.03 cc. prepared as previously described (1) and contained 
0.015 cc. of serum.  The results are given in Table III. 
The  outcome  of  this  experiment  is  plain:  the  antiserum  in  the 
mixtures protected against  10  infective nasal  units of virus by  the 
intranasal,  as  against  1,000,000  intramuscular  doses  by  the  intra- 
muscular route.  There is very little difference in effect when immune 770  VIRUS  01  e  EQDTNE  ENCEPHALOMYELITIS.  II 
serum is mixed with virus just before animal inoculation or when 
the serum is given separately and prior to  the virus.  Here  again 
occurs the wide variation in protective capacity elicited by two routes 
of inoculation. 
The data can be related to the pathways traversed by the virus 
after inoculation by these various routes.  With the intranasal and 
intracerebral methods, the virus  enters nervous tissue immediately 
since in the former it progresses along the olfactory pathway to the 
brain, and in the latter it is placed within the brain itself, the cells 
of which it attacks directly.  But after inoculation into the peritoneal 
cavity or into the muscles, virus circulates in the blood and is demon- 
TABLE III 
Comparison of InfecthCty by Intranasal and Intramvzcular Routes 
Minhnsl infective 
Number of mice developing  encephalitis  doses in terms of route, 
Route of  of three injected  against which 
inoculation  there was protection 
of serum- 
virus 
mixtures 
Serunl 
in 
im  HR 
lO-I  IO-~ lOS 
--  1  3 
3 
I  0  0 
10-4 
~tr~tsnJ  Intxa- 
10-~  10-6 10-7 lO-S 10-9  doses  muscular 
doses 
0  10 
2  Control 
1,000,00q 
3  1  0  Control 
Abbreviations as in Table I. 
HR, hyperimmune rabbit serum; NR, normal rabbit serum. 
strable  there  (9,  10).  Thus it  appears  that  the  large  amounts of 
protection may in  some way be  related to  an  action occurring at 
the peripheral site or during the passage of the virus  through the 
blood on its way to the central nervous system.  Attention was then 
turned to a study of the relation of the circulating blood to the mech- 
anism of the immune reaction. 
Virus  in  Blood  Following  Intraperitoneal  Injections  of Serum-Virus 
Mixtures 
It has been shown (9,  10) that virus may be detected in the blood 
of young mice inoculated intraperitoneally or  intramuscularly.  In 
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the blood at  1,  2,  4, and 24 hours (longer periods of time were not 
studied) after intraperitoneal introduction of virus, which is in general 
agreement with the prior observations.  The plan  of  the following 
tests was to inject serum-virus mixtures by this route and to observe 
whether virus could be detected later in the blood stream. 
Mixtures of 10 -s dilution of virus (1,000 cerebral infective units) and hyper- 
immune rabbit serum were injected intraperltoneally (dose 0.03 cc.) in a group 
of 14 day old mice.  At the same time 10  -6, 10  -7, and l0 -s dilutions of virus mixed 
with normal serum were slmil~rly  inoculated into another group.  24 hours later 
subgroups of each were bled to death by cardiac puncture by means of syringes 
washed with sterile 1:500 solution of heparin.  The blood secured was directly 
transferred to other mice intracerebrally (dose 0.03 cc.).  The remainder of the 
animals which were not bled were observed for signs of infection with the virus, 
as controls.  The results are summarized in Table IV. 
It is  clear  from Table  IV  that  by the  methods used,  virus was 
detected in the blood 24 hours after intraperitoneal injection of nor- 
real  serum-virus  mixtures  but  not  in  the  animals  receiving  the 
immune serum. 
The work of Smith  (14),  Long and Olitsky (15),  and Sabin  (16) 
has  shown  that  after  intravenous  injection  of  vaccine  virus  into 
normal rabbits,  the virus can be demonstrated in the whole blood. 
However,  following similar  injections of  immune  serum-virus  mix- 
tures,  or  of virus into immune rabbits,  the  infective agent  can  be 
recovered from leucocytes but  not from whole blood.  An attempt 
was therefore made to search  for virus in the leucocyte suspensions 
in  mice  given  normal  and  immune  serum-virus  mixtures  intraper- 
itoneally. 
Groups of mice were inoculated intraperitoneally with normal and immune 
serum-virus mixtures as in the last experiment.  The same samples of serum were 
used; dilution of virus was 10-s; dose, 0.03 cc.  Mice  were 14 and 15 days old. 
24 hours later they were bled from the heart as before and the heparinized blood 
from each of the two groups of animals was pooled.  The washed  buffy coat of the 
centr~uged blood was secured and injections of these leucocyte-contalning  sus- 
pensions were made into adult mice in groups of six.  The result was that all the 
mice receiving leucocyte suspensions derived from mice given normal serum-virus 
mixtures died and an those injected with immuneoserum  preparations survived. 
By means of the methods  here employed virus was found to  be 
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normal  serum-virus  mixtures were given  intraperitoneally.  By  the 
same methods, no virus was apparently detectable in these materials 
TABLE IV 
Test for the Presence of Virus in the Whole Blood of Mice 24 Hours after Intraperi- 
toneal Inoculation with Normal and Immune-Serum-Virus  Mixtures, 
Respectively 
Mouse No, 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
Dilution of virus 
in mixture given 
intrkperltoneaUy 
10  -3  HR 
10-~  ,, 
10--8  ,, 
10--3  ,, 
10  ~  ,, 
10 ~  ,, 
10  ~  NR 
10-8  ,, 
10--3 
10  ~  ,, 
10-~  ,, 
10-3  ,, 
10  ~  ,, 
10-6  ,, 
10-6  ,, 
10-7  ,, 
10-7  ,, 
10-7 
10-s  ,¢ 
10  ~  ,, 
10-s  ,, 
Serum  Fate of ones not 
bled 
E 
~c 
~c 
Results of test for 
virus in the 
whole blood* 
0/3 
0/3 
O/3 
t 
3/3 
3/3 
3/3 
S, survived; E, encephalitis and death. 
Other abbreviations as in Tables I and III. 
* Numerator indicates the number of mice developing encephalitis;  denominator 
indicates the number injected. 
t No blood obtained. 
after  immune  serum-virus  preparations  were  similarly  introduced 
into mice. 
In Vitro Effed of Normal Mouse Blood on Serum-Virus Mixtures.-- 
While these tests for virus in the blood could not be considered con- 
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serum prevents  the  circulation of virus in  the blood.  The precise 
mechanism by which this is  done is  not  apparent.  Although it is 
known that serum does not  have an inactivating effect in the test 
tube, there was a possibility that the whole blood of the normal animal 
might enhance the action of antiviral bodies.  The following experi- 
ment was performed to test this point. 
Hyperlrnmune rabbit serum plus normal heparinized blood obtained by pooling 
whole blood from 18 normal, 15 day old mice, plus dilutions of virus in broth, were 
mixed, using 0.3  cc. of each ingredient.  The final dilutions of virus were 10 -1 
to 10 -9  . 
TABLE  V 
Effect of Heparinized Blood on the Protective Power of Serum  When Mixtures  of 
Blood, Serum, and Virus Are Injected Intracerebrally 
Blood, 
or broth  control 
Blood 
Broth 
(control) 
;ertm 
HR 
NR 
HR 
NR 
Number of mice developing  encephalitis 
of three injected 
!  !  3_  3_  3_  o  ;o ' ol 
I  Minimal  cerebral 
infective doses of virus 
against which the 
serum protected with 
Broth 
1,000 
Control 
Abbreviations as in Table I. 
* Undetermined but equal to or less than the amount indicated. 
Another mixture was prepared in precisely the same way except that normal 
rabbit serum was substituted for the immune serum; other controls are also shown 
in Table V.  Of each of these materials, 0,03 cc. was withdrawn and injected in- 
tracerebraUy in mice.  These  components  were  in contact in the test tube during 
the period of animal inoculations, which contact hsted from about  10 minutes 
before the first injection to about 30 before the last. 
It will be noted from the table that normal mouse blood in vitro 
probably  contained  no  factor  enhancing  the  protective  power  of 
immune serum, nor was the immune reaction found to be completed 
therein.  It  is  natural to  conclude from all  these  tests with blood 
that under the influence of immune serum after intraperitoneal injec- 
tion of serum-virus mixtures, virus is not found in the blood. 774  VIRUS  OF  EQUINE  ENCEPHALOMYELITIS.  II 
R&um~ 
In the first paper of this series  (1)  it was  shown that antiserum 
against equine encephalomyelitis virus protected against many more 
minimal infective doses when serum-virus mixtures were given intra- 
peritoneaUy, instead of intracerebrally.  It was indicated that  this 
variation in protective capacity by two routes of inoculation (a)  was 
not due to inactivation of virus by serum in vitro,  (b)  that it did not 
depend on the greater sensitivity of tissues to detect virus, nor  (c) 
on the amount of inoculum, nor (d) on incubation of the mixtures. 
The purpose of the present investigation was to throw more light 
on the mechanism underlying the phenomenon.  Our procedure con- 
sisted of passive immunization of  12  to  15  day old mice by intra- 
peritoneal inoculation of hyperimmune serum followed by virus given 
in the brain, nose, muscles or peritoneal cavity.  When intracerebral 
or intranasal inoculations of virus were given, only minimal protection 
or none at all was demonstrated; when intramuscular or intraperito- 
heal injections were made, a marked protection was revealed.  Further 
experiments exhibited  an  agreement in  effect when  antiserum and 
virus were mixed and then without incubation were introduced into 
animals.  The  results  bring  out  the  fact  that  a  relatively  minute 
amount of antiserum (0.015  cc.) has the capacity to protect against 
a  remarkably high amount of virus given intramuscularly or intra- 
peritoneally,  even  against  as  many  as  1,000,000  to  10,000,000  in- 
fective doses. 
The experimental findings on the variation in the protective capacity 
by different routes of inoculation appear to be correlated with the 
pathways traversed by the virus from the periphery to the central 
nervous system.  Since after intraperitoneal or intramuscular inocu- 
lation the pathway includes the circulating Mood, studies were made 
on  the  blood.  After  introduction  of  serum-virus  mixtures  intra- 
peritoneally, virus was not found in the circulation 24 hours later. 
DISCUSSION 
An interpretation of the results will be proposed on the basis of 
existing knowledge as to the pathways traversed by the virus of equine 
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It is known (8) that vires given intranasaUy in mice reaches the brain 
by the olfactory chain of neurons and this pathway is thus entirely 
within nervous  tissue.  Also,  virus placed within  the  brain  comes 
into  direct  contact with  the  nerve cells.  After intramuscular  and 
intraperitoneal inoculation, however, virus, in the greater number of 
mice, reaches the central nervous system from the periphery through 
the mediation of the blood stream.  That is, the infective agent is 
deposited from the blood onto the nasal mucosa whence the invasion 
of the brain is by way of the olfactory pathway (9, 10).  The experi- 
ments have shown that when the pathway of virus is only in nervous 
tissue there occurs little or no protection by antiserum; when the 
pathway includes the circulating blood, on the other hand, the pro- 
tective capacity is great, even though relatively minute amounts of 
antiserum are used. 
Interest  centers on  the point  along the pathways  taken by  the 
virus where the immune effect is consummated.  It is not likely to 
be in the brain because after the intraperitoneal injectionof antiserum 
there is often neutralization of only one minimal intracerebral infective 
dose of virus or even none at all.  Because of the fact that after intra- 
muscular or intraperitoneal injection of  virus  it  migrates  in  most 
cases from the blood stream to the nasal mucosa, there was the pos- 
sibility that  the immune reaction took place on the nasal mucosa. 
However, it was found that when serum is given intraperitoneally 
and followed by virus intranasally, little or no protection occurred, so 
that this possibility seemed unlikely.  By elimination, then, the most 
important part  of the immune reaction is probably  effected some- 
where in non-nervous  tissue.  But  the experiments  leave undeter- 
mined the exact tissue or site of the reaction. 
In the latter connection, antiserum injected intraperitoneaUy fol- 
lowed by virus intramuscularly results in a  high degree of protec- 
tion.  If the action of the serum is to protect the muscle cells at the 
local site of inoculation, antibody must have entered the blood stream 
before  reaching the  muscle.  Plainly, great  diffusion is possible  in 
the blood and therefore the suggestion alluded to earlier that anti- 
vaccinal serum is more effective in one tissue than in another because 
of less diffusion (4) may not apply here.  Although by the methods 
used virus was not shown to be present in the blood 24 hours after 776  VIRUS  0]~  EQUINE  ENCEPHALOMYELITIS.  II 
intraperitoneal  inoculation  of  serum-virus  mixtures,  no  conclusive 
proof  is adduced  from this fact and  from the in vitro  experiments 
as reported, that the reaction takes place in the blood stream.  Sabin 
(13)  had  previously  demonstrated  that  with  the  virus  now  under 
investigation the prior nasal instillation of antiserum produces resist- 
ance against infection by the same route, 2 to 4 hours later, provided 
the dose of virus is not too great, by virtue of the local specific pro- 
tective action on the cells by the serum. 
A  corollary may be offered to strengthen the general proposition 
that  the protective capacity varies,  depending on whether nervous 
or non-nervous tissues are included in the pathways of virus progres- 
sion  to  the  central nervous system from  the point  of  inoculation. 
Sabin (3,  13,  17,  18) has shown that, following injection of pseudo- 
rabies (or B  virus) intramuscularly, the virus multiplies locally and 
then progresses to the central nervous system by way of the peripheral 
nerves; furthermore, injection of serum-virus mixtures intramuscularly 
results in protection, while intracerebrally there is none.  It is pos- 
sible that the difference may be ascribed  (18)  to the fact that the 
antiserum prevents the local multiplication of virus  and hence no 
progression along peripheral nerves occurs.  Pseudorabies antiserum- 
virus mixtures are infective intracerebrally even when minimal doses 
of virus are used, but do prevent infection when administered by the 
intranasal  (or  subcutaneous)  route.  The  question  is  whether  the 
antiserum here acts in the same way to prevent local multiplication 
of virus and so no further progression can take place.  By way of 
contrast, pseudorabies virus does not take the olfactory pathway as 
equine  encephalomyelitis does  (8),  therefore  the  intranasal  route 
is  one  by  which  pseudorabies  virus  progresses  first  through  non- 
nervous tissue;  consequently one should expect a  higher protective 
capacity by this route than by the intracerebral. 
One final point, perhaps of practical bearing, remains for discus- 
sion,--ff one assumes that in the horse as in the mouse immunity 
which results  from  circulating  antibody  depends  similarly  on  the 
route of inoculation of virus.  The most probable hypothesis as to 
the mode of  transmission  in nature of  equine encephalomyelitis is 
that the virus is carried by mosquitoes.  If this is so, the portal of 
entry is such in natural infection as to correspond with intraperitoneal PETER  K.  OLITSKY AND  CARL G.  HAI~OPJ)  777 
or intramuscular inoculation in the mouse, and the immunity from 
circulating antibodies  might  be  expected  to  be  maximal.  Such  a 
state of affairs would  explain the effective use of antiserum in the 
field as a prophylactic agent (19, 20). 
CONCLUSIONS 
Minute  amounts  of  antiserum  injected intraperitoneally protect 
against  large  doses  of  equine  encephalomyelitis virus  given  intra- 
muscularly or intraperitoneally in 12 to 15 day old mice.  Antiserum 
given  intraperitoneally  with  virus  intracerebrally  or  intranasally 
results in little or no protection.  These phenomena occur as well 
when serum-virus mixtures are injected at the different sites.  The 
marked  variation  of  the protective  capacity of  antiserum  as  thus 
displayed would appear to be dependent upon the differing pathways 
of progression of the virus from the site of injection to the central 
nervous system. 
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